BeStock  
Stocks › Medical Devices › BRKR

Bruker Corp BRKR

US equityMarket cap rank #1533Medical DevicesRoom-Temp Superconductors
$56.46 −$5.64 (-9.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.46 0.00%
Open$60.65
Prev close$62.10
Day range$56.13 – $61.10
Volume2.25M
Market cap$8.62B
P/E (TTM)–
Dividend yield0.35%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$874.00M+1.6% YoY
Operating profit$110.80M+187.0% YoY
Net profit-$109.70M-87.5% YoY
Diluted EPS-$0.81-97.6% YoY
Free cash flow$96.70M+278.7% YoY
Operating cash flow$118.20M

Revenue, last 8 quarters

$979.6MDec '24$801.4MMar '25$797.4MJun '25$860.5MSep '25$977.2MDec '25$823.4MMar '26$838.5MJun '26$874.0MSep '26

Net profit, last 8 quarters

$13.9MDec '24$16.8MMar '25$4.2MJun '25$-58.5MSep '25$29.2MDec '25$15.7MMar '26$-50.9MJun '26$-109.7MSep '26

Diluted EPS by quarter

0.09Dec '240.11Mar '250.05Jun '25-0.41Sep '250.10Dec '250.02Mar '26-0.41Jun '26-0.81Sep '26

Free cash flow by quarter

$153.3MDec '24$39.0MMar '25$-148.8MJun '25$-54.1MSep '25$177.8MDec '25$47.0MMar '26$-106.2MJun '26$96.7MSep '26

Annual revenue

$2.0BFY20$2.4BFY21$2.5BFY22$3.0BFY23$3.4BFY24$3.4BFY25

Profitability & balance sheet

Gross margin47.7%
Operating margin9.5%
Net margin-4.8%
Return on equity-7.1%
Return on assets-2.7%
Return on invested capital-3.6%
Current ratio1.84
Liabilities / assets59.8%
Cash & investments$167.00M
Total debt$1.71B
Net cash (debt)-$1.55B
Free cash flow / sales6.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Bruker Scientific Instrument (BSI) BIOS$397.20M 45.3%
  • Bruker Scientific Instrument (BSI) Nano$263.10M 30.0%
  • Bruker Scientific Instrument (BSI) Microbiology and Infection Diagnostics (BMID)$133.60M 15.3%
  • Bruker Energy & Supercon Technologies (BEST)$82.10M 9.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $874.00M $838.50M $823.40M $3.44B $977.20M
Total Operating Revenue $874.00M $838.50M $823.40M $3.44B $977.20M
Cost of Revenue $444.70M $422.50M $443.60M $1.86B $528.00M
Gross Profit $429.30M $416.00M $379.80M $1.58B $449.20M
Operating Expense $318.50M $333.20M $343.40M $1.34B $346.80M
Selling and Admin Expenses $226.50M $238.90M $242.10M $946.50M $247.20M
-General & Admin Expense $226.50M – $242.10M – –
Research & Development $92.00M $94.30M $101.30M $395.20M $99.60M
Operating Profit $110.80M $82.80M $36.40M $236.00M $102.40M
Net Non-Operating Interest Income (Expense) -$6.20M -$2.50M -$4.30M -$46.70M -$18.20M
Non-Operating Interest Income $7.70M $15.30M $7.90M $14.80M $4.60M
Non-Operating Interest Expense $15.40M $17.80M $12.20M $60.30M $11.20M
Total Other Finance Costs -$1.50M – – $1.20M $11.60M
Other Income (Expense) -$224.90M -$121.00M -$10.20M -$167.30M -$16.00M
Gain on Sale of Security $2.80M $3.60M $16.60M $17.50M $9.30M
Earnings from Equity Interest $9.70M $27.60M – – –
Special Income (Charges) -$235.90M -$151.10M -$25.90M -$171.70M -$25.10M
-Less:Restructuring and Mergern & Acquisition $25.40M $9.40M $12.40M $5.10M -$14.40M
-Less:Impairment of Capital Assets $174.90M $137.60M $12.90M $111.30M $2.00M
-Less:Write Off $35.60M $4.10M $600,000.00 $20.00M $2.20M
Other Non-Operating Income (Expenses) -$1.50M -$1.10M -$900,000.00 -$13.10M -$200,000.00
Pretax Profit -$120.30M -$40.70M $21.90M $22.00M $68.20M
Tax -$12.20M $14.20M $2.50M $29.30M $37.80M
$1.60M -$4.00M $3.70M $1.00M $1.20M
Net Profit -$109.70M -$50.90M $15.70M -$8.30M $29.20M
Profit from Continuing Operations -$109.70M -$50.90M $15.70M -$8.30M $29.20M
Minority Interests $2.10M $1.10M $1.30M $300,000.00 $3.20M
Net Income to Parent Company -$111.80M -$52.00M $14.40M -$8.60M $26.00M
Preferred Stock Dividends $11.00M $10.90M $10.90M $13.90M $11.10M
Net Income to Common Stockholders -$122.80M -$62.90M $3.50M -$22.50M $14.90M
Basic EPS -$0.81 -$0.41 $0.02 -$0.15 $0.10
Diluted EPS -$0.81 -$0.41 $0.02 -$0.15 $0.10
Dividend Per Share $0.05 $0.05 $0.05 $0.20 $0.05
-Less:Other Special Charges – – – $35.30M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $5.83B $6.05B $6.13B $6.24B $6.24B
Total Current Assets $2.16B $2.23B $2.10B $2.21B $2.21B
Cash and Cash Equivalents & Short-Term Investments $167.00M $222.50M $133.40M $298.80M $298.80M
-Cash and Cash Equivalents $119.70M $184.90M $133.40M $298.80M $298.80M
-Short Term Investments $47.30M $37.60M – – –
Receivables $793.00M $776.60M $750.40M $736.00M $736.00M
-Accounts Receivable $563.90M $545.90M $542.70M $544.90M $544.90M
-Taxes Receivable $110.00M $114.70M $84.80M $74.20M $74.20M
-Other Receivables $119.10M $116.00M $122.90M $116.90M $116.90M
Prepaid Assets $65.00M $78.90M $69.20M $59.00M $59.00M
Inventory $1.10B $1.12B $1.12B $1.09B $1.09B
Other Current Assets $29.40M $26.90M $29.10M $24.10M $24.10M
Total Non-Current Assets $3.67B $3.83B $4.03B $4.03B $4.03B
Net PPE $695.70M $714.10M $719.60M $910.60M $910.60M
Goodwill and Other Intangible Assets $2.15B $2.30B $2.48B $2.45B $2.45B
-Goodwill $1.29B $1.43B $1.57B $1.55B $1.55B
-Other Intangible Assets $859.20M $867.80M $902.40M $899.60M $899.60M
Other Non-Current Assets $826.70M $816.20M $832.20M $249.30M $249.30M
Total Liabilities $3.49B $3.62B $3.63B $3.73B $3.73B
Total Current Liabilities $1.17B $1.20B $1.36B $1.28B $1.28B
Payables $207.80M $200.20M $269.10M $324.90M $324.90M
-Accounts Payable $207.80M $200.20M $269.10M $215.90M $215.90M
Short-Term Debt and Capital Lease Obligation $10.40M $10.10M $8.40M $51.80M $51.80M
-Current Debt $10.40M $10.10M $8.40M $16.60M $16.60M
Current Deferred Liabilities $428.80M $444.60M $479.70M $441.30M $441.30M
Other Current Liabilities $525.10M $549.80M $597.90M $165.10M $165.10M
Total Non-Current Liabilities $2.31B $2.41B $2.27B $2.45B $2.45B
Long Term Debt and Capital Lease Obligation $1.70B $1.81B $1.66B $1.99B $1.99B
-Long Term Debt $1.70B $1.81B $1.66B $1.85B $1.85B
Other Non-Current Liabilities $610.20M $597.70M $609.90M $239.20M $239.20M
Total Equity $2.34B $2.44B $2.50B $2.51B $2.51B
Stockholders' Equity $2.29B $2.38B $2.45B $2.46B $2.46B
Capital Stock $1.80M $1.80M $1.80M $1.80M $1.80M
-Common Stock $1.80M $1.80M $1.80M $1.80M $1.80M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.44B $1.43B $1.42B $1.41B $1.41B
Retained Earnings $2.16B $2.29B $2.36B $2.36B $2.36B
Less: Treasury Stock -$1.24B -$1.24B -$1.24B -$1.24B -$1.24B
Gains/Losses Not Affecting Retained Earnings -$67.90M -$96.80M -$90.20M -$79.50M -$79.50M
Minority Interests $57.40M $54.40M $53.70M $53.80M $53.80M
-Gross PPE – – – $1.60B $1.60B
-Accumulated Depreciation – – – -$692.00M -$692.00M
Non-Current Deferred Assets – – – $421.70M $421.70M
-Total Tax Payable – – – $97.50M $97.50M
-Dividends Payable – – – $11.50M $11.50M
Current Accrued Expenses – – – $116.40M $116.40M
-Current Capital Lease Obligation – – – $35.20M $35.20M
-Long Term Capital Lease Obligation – – – $138.60M $138.60M
Non-Current Deferred Liabilities – – – $221.60M $221.60M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $118.20M -$77.40M $71.20M $134.10M $229.80M
Net cash flow from continuing operations $118.20M -$77.40M $71.20M $134.10M $229.80M
Net Income from Continuing Operations -$109.70M -$50.90M $15.70M -$8.30M $29.20M
Gain/Loss from Continuing Operations -$8.20M – – -$56.00M -$55.60M
Depreciation & Depletion & Amortization $54.10M $58.00M $58.30M $220.30M $58.10M
Deferred Tax -$58.40M – – -$104.50M -$39.30M
Other Non-Cash Items $31.90M -$4.50M $21.40M -$21.10M $59.50M
Change in Working Capital -$13.30M -$196.90M -$24.20M -$144.80M $124.20M
-Change in Inventory -$4.90M -$23.70M -$47.20M $12.10M $73.60M
-Change in Payables and Accrued Expense $5.20M -$137.50M $11.20M -$158.20M $65.20M
-Change In Other Working Capital -$13.60M -$35.70M $11.80M -$52.90M -$68.80M
Net cash flow from investing -$72.70M -$25.30M -$39.70M -$196.50M -$55.50M
Net Cash Flow from Continuing Investing Activities -$72.70M -$25.30M -$39.70M -$196.50M -$55.50M
Net PPE Purchase and Sale -$21.50M -$28.80M -$24.20M -$90.80M -$22.60M
Net Business Purchase and Sale -$57.00M $0.00 -$16.00M -$73.90M -$4.20M
Net Other Investing Changes $5.80M $3.50M $500,000.00 $4.80M $7.90M
Financing Cash Flow -$110.10M $149.20M -$204.90M $135.10M -$167.60M
Net Cash Flow from Continuing Financing Activities -$110.10M $149.20M -$204.90M $135.10M -$167.60M
Net Issuance Payments Of Debt -$57.70M $167.70M -$181.30M -$491.30M -$144.60M
Cash Dividends Paid -$18.70M -$18.50M -$18.60M -$32.90M -$17.60M
Net Other Financing Charges -$33.70M $0.00 -$5.00M -$8.30M -$3.50M
Ending Cash Balance $123.80M $189.10M $137.60M $303.10M $303.10M
Net Change in Cash -$64.60M $46.50M -$173.40M $72.70M $6.70M
Beginning Cash Balance $189.10M $137.60M $303.10M $186.70M $297.30M
Effect of Exchange Rate Changes -$700,000.00 $5.00M $7.90M $43.70M -$900,000.00
Free Cash Flow $96.70M -$106.20M $47.00M $13.90M $177.80M
Net Common Stock Issuance – – $0.00 -$2.10M $3.80M
-Change in Receivables – – – $54.20M –
Net Intangibles Purchase and Sale – – – -$29.40M –
Net Investment Purchase and Sale – – – -$7.20M –
Net Preferred Stock Issuance – – – $669.70M $200,000.00

Discussion

No comments yet — be the first to weigh in on BRKR.

Sign in to join the discussion.

Scroll to Top